Hera News & Events

­

Chimeric Humanized Mouse Models: Understanding Human and Mouse Cell Interactions

Humanized liver mouse models are increasingly being used in preclinical [...]

By |February 28th, 2017|

Transposon Mutagenesis Helps Identify Genes Mediating Drug Resistance in the Treatment of CLL

First time treatment of Chronic Lymphocratic Leukemia (CLL) generally requires [...]

By |February 28th, 2017|

PDX Models of Lung Cancer Closely Mimic Characteristics of Patient Primary Tumors

Despite ongoing research, lung cancers have remained among the most [...]

By |February 28th, 2017|

Rat Provides a More Robust & Convenient Animal Infection Model for Hepatitis E Virus

Hepatitis E virus (HEV) is estimated to cause more than [...]

By |December 21st, 2016|

Hera BioLabs, a KY based contract research lab announces $400K Kentucky SBIR/STTR Matching Funds Grant

Hera BioLabs (“Hera”), a Lexington KY based contract research organization [...]

By |December 14th, 2016|

Transgenic Rats as Research Models Boast Significant Benefits….

Transgenic Rats as Research Models Boast Significant Benefits over Mouse [...]

By |November 30th, 2016|

Humanized Mouse Xenograft Models: The Best of Both Worlds

Xenograft rodent models and cultured cells have long been used [...]

By |November 30th, 2016|

Xenograft Rat Models Give Hope to New Therapeutic Treatments for Leukemia

Mutations in DNA methyltransferase 3A (DNMT3A) are common in acute [...]

By |November 30th, 2016|

Hera BioLabs in Genetic Engineering News

Hera BioLabs and our VP of Research and Development Tseten [...]

By |October 28th, 2016|

Advancements in Stem Cell-Based Therapies for Malignant Brain Tumors

Despite many great developments in the overall treatment of cancers, [...]

By |October 26th, 2016|